Love Potion #1
Sativa (sativa-dominant) · Lineage: Bred by Reeferman Seeds, commonly given as G13 crossed with Santa Marta Colombian Gold.
· How this profile is built: type, lineage, cannabinoid figures and the flavor, terpene and effect terms are aggregated from public cultivar records, and the summary is generated from those fields rather than copied from any third party. Per-record source citations and check dates are not stored yet. Batch-level lab numbers, when a certificate of analysis is linked below, are the verified figures.
Love Potion #1 is a sativa-dominant hybrid from Canada's Reeferman Seeds, commonly given as G13 crossed with a Santa Marta Colombian Gold line. It earned Cannabis Cup recognition in the mid-2000s, with the breeder citing a 2004 win that anchored the cultivar's reputation and spawned numbered follow-ups. The release paired storied American and Colombian genetics at a moment when Canadian breeders were competing directly with the Dutch seed houses.
Profile
Flowers are typically medium-sized and lightly built in the older sativa style, with pale green calyxes, long pistils, and a fine trichome layer generally reported as medium to heavy for its era. The aroma commonly leads with sweet lemon and cream over floral and lightly earthy depth, a softer profile than the diesel lines that dominated the same period. Flavor on the exhale is generally described as sweet citrus with a smooth, creamy finish. Terpinolene, limonene, and myrcene are among the terpenes most frequently reported for flower grown from this line.
Reported effects
Consumers commonly report a warm, euphoric lift with a talkative, affectionate mood, a pattern long tied to the cultivar's name. Some consumers commonly report gentle relaxation arriving late in a session without displacing the mental brightness. Reported experiences vary considerably with individual tolerance, product selection, and consumption method, and these descriptions do not represent medical or therapeutic outcomes.
Consumer-reported descriptors for general information — not medical advice; no therapeutic claims are made.
Cultivation notes
Growers typically report a flowering period of 9 to 10 weeks, with tall, open growth and flexible branches that respond well to training. The line is generally described as moderately demanding, wanting warmth and light intensity to finish well at northern latitudes. Yields are generally described as moderate, with aroma cited as the trait that justified its competition pedigree.
Reported effects
EuphoricRelaxedTalkativeFlavors
CitrusDieselEarthyFloralSweetWhere to find it
No business-provided menus list this strain yet — menus appear as stores claim their listings. Find licensed stores near you and ask.
Frequently asked
What competition history does Love Potion #1 have?
Reeferman Seeds cites a 2004 High Times Cannabis Cup win, and contemporary coverage places the cultivar among the recognized entries of that period. This site reports such placements as breeder-cited competition results from a specific event rather than standing rankings.
Are there other Love Potion strains?
Yes. Reeferman released numbered follow-ups, with Love Potion #9 the most cited, drawing on related Colombian-influenced genetics. The numbered names distinguish separate releases in the same breeding project rather than phenotypes of a single cultivar.
Tastes like
Similar cultivars
Record activity
- Jul 16, 2026 — Record first published on this platform.
This platform logs changes it makes to its own record. It is not a log of the business's activity, and an absence of entries is not a finding about the business.
Spot something wrong?
Tell us which field is inaccurate and what it should be. No account needed. Nothing you submit publishes automatically — a reviewer checks every correction first, and accepted corrections are logged publicly on this page with the date. Business record fields only; please do not submit personal information about any individual.
Effects and flavors are reported by consumers and sources for general information only. This is not medical advice and makes no therapeutic claims.